Longitude Variation of the microRNA-497/FGF-23 Axis during Treatment and Its Linkage with Neoadjuvant/Adjuvant Trastuzumab-Induced Cardiotoxicity in HER2-Positive Breast Cancer Patients

PURPOSE: MicroRNA-497 (miR-497) is previously reported to target fibroblast growth factor 23 (FGF-23) and regulates cardiac injury, while their value in predicting drug-induced cardiotoxicity is not reported. Thus, the current study aimed to investigate the correlation of miR-497/FGF-23 with neoadju...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Hu, Xiaoyan, Wang, Lingyun, Du, Tao, Feng, Jing, Li, Ming, Liu, Lei, Liu, Xiaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130632/
https://www.ncbi.nlm.nih.gov/pubmed/35647022
http://dx.doi.org/10.3389/fsurg.2022.862617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130632/
https://www.ncbi.nlm.nih.gov/pubmed/35647022
http://dx.doi.org/10.3389/fsurg.2022.862617

Ejemplares similares